发明名称 Treatment of Charles-Bonnet syndrome, involves administration of serotonin reuptake inhibitor, e.g. venlafaxine or citalopram, to cause rapid and permanent eradication of hallucinations
摘要 <p>The use of a medicament containing at least one serotonin reuptake inhibitor (I) for the treatment of Charles-Bonnet syndrome (CBS) is new. ACTIVITY : Neuroleptic. MECHANISM OF ACTION : Serotonin reuptake inhibitor.</p>
申请公布号 DE102006040278(A1) 申请公布日期 2008.03.20
申请号 DE20061040278 申请日期 2006.08.21
申请人 TECHNISCHE UNIVERSITAET DRESDEN 发明人 LANG, UNDINE
分类号 A61K45/00;A61P27/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址